| Followers | 2421 |
| Posts | 92347 |
| Boards Moderated | 1 |
| Alias Born | 09/12/2003 |
Saturday, October 28, 2023 2:58:41 PM
Thank you, I am well aware in the study mice were put into groups, PrimiCell® and the control group. The PrimiCell® group was given PrimiCell® for seven days prior to the treatment that was in the year 2014. Back then company was run by the Chairman and CEO, Barry Epling currently is no longer in control of the company.
I've mentioned it many times, repeatedly. No matter how exceptional the product may be, it's destined for obsolescence if the company lacks the knowledge of how to effectively market it. Marketing is the cornerstone of any company's success. Presently, we have a new owner and a new management team in place with a proven track record of success in their history. However, having a successful history doesn't guarantee their ability to market the product effectively.
I've observed, based on your past interactions on various discussion boards, that very little seems to impress you, especially on the BDPT board none of your input is positive. There must be a compelling reason for you to invest your valuable time here. Could you kindly share with us what aspects of the company attract you to participate in these discussions?
I've mentioned it many times, repeatedly. No matter how exceptional the product may be, it's destined for obsolescence if the company lacks the knowledge of how to effectively market it. Marketing is the cornerstone of any company's success. Presently, we have a new owner and a new management team in place with a proven track record of success in their history. However, having a successful history doesn't guarantee their ability to market the product effectively.
I've observed, based on your past interactions on various discussion boards, that very little seems to impress you, especially on the BDPT board none of your input is positive. There must be a compelling reason for you to invest your valuable time here. Could you kindly share with us what aspects of the company attract you to participate in these discussions?
Recent BDPT News
- BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night • GlobeNewswire Inc. • 04/28/2026 02:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/14/2026 08:05:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 02:45:46 AM
- BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing • GlobeNewswire Inc. • 10/07/2025 03:48:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 07:16:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 08:05:36 PM

